化疗在治疗三阴性乳腺癌中的重要性

大约10%到20%的乳腺癌是三阴性的, 最具侵袭性的乳腺癌之一. Triple negative breast cancer (TNBC) patients have a 77% five-year survival rate compared to 93% of women with other types of breast cancer, in part because they are less likely to pursue 化疗 treatments that offer the highest chance of survival.

为了提高存活率和健康状况, the CDC Division of Cancer Prevention and Control engaged with the National Association of Chronic Disease Directors and health simulation company Kognito, 健康教育模拟的主要开发者, 创建了“和别人谈谈:三阴性乳腺癌”.”

“Talk to Someone: Triple Negative Breast Cancer” is an online and mobile app in which TNBC patients engage in an interactive conversation with Linda, 一个虚拟的TNBC幸存者. 用户通过提出关于TNBC的问题来引导对话, 化疗, 治疗期间的生活, 以及琳达的继承权. 对话的目的是让患者更好地了解他们的诊断, 更好地理解化疗的优点, 并知道从治疗中可以期待什么, 为了提高化疗的动力.

“Talk to Someone: Triple Negative Breast Cancer” is available online and as a mobile app for the general public and for oncology providers to e-prescribe to newly diagnosed patients.

为了和琳达谈谈诊断和治疗， 点击这里，或在app Store或Google Play Store下载.